Cases & Deals

Share

Inveni purchases shares in Priaxon

May 2008

Client(s) Inveni Fund I Oy

Jones Day represented Inveni Fund I Oy in connection with its purchase of Common Stock in a private placement by Priaxon AG, a research company focusing on medicinal chemistry and drug discovery for small molecule therapeutics.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.